Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Dec;73(12):8407-10.
doi: 10.1128/IAI.73.12.8407-8410.2005.

Clostridium perfringens enterotoxin damages the human intestine in vitro

Affiliations

Clostridium perfringens enterotoxin damages the human intestine in vitro

M E Fernández Miyakawa et al. Infect Immun. 2005 Dec.

Abstract

In vitro, Clostridium perfringens enterotoxin (CPE) binds to human ileal epithelium and induces morphological damage concurrently with reduced short-circuit current, transepithelial resistance, and net water absorption. CPE also binds to the human colon in vitro but causes only slight morphological and transport changes that are not statistically significant.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Time course effect of CPE on (A) transepithelial net water flux (ΔJw), (B) short-circuit current (ΔIsc), and (C) transepithelial resistance (ΔRt) in human ileum. After an equilibration period, intestinal mucosal sheets placed in Ussing chambers were incubated at the mucosal side with either Ringer solution alone (solid line) or Ringer solution containing 10 μg/ml of CPE (dotted line) and monitored for 60 min. Each point indicates the mean ± standard error of the mean of four experiments.
FIG. 2.
FIG. 2.
Morphological effect of CPE on human ileal mucosa. (a) Human ileum after 60 min of incubation with Ringer solution (control) in Ussing chamber. No significant histological abnormalities were observed. Hematoxylin and eosin, 400×. (b) Human ileum treated with CPE in an Ussing chamber for 60 min. Observe the necrosis and desquamation of the superficial epithelium at the tips of the villi. Hematoxylin and eosin, 400×. Bars, 40 μm.
FIG. 3.
FIG. 3.
Binding of CPE on human intestine. (a) Human ileum treated with CPE in an Ussing chamber for 60 min. Observe positively stained CPE on the apical borders of the enterocytes. Avidin biotin peroxidase, anti-CPE primary antibody, 400×. (b) Human ileum treated with CPE in an Ussing chamber for 60 min. Avidin biotin peroxidase, normal rabbit serum (negative control), 400×. (c) Human colon treated with CPE in an Ussing chamber for 60 min. Observe positively stained CPE on the apical and basolateral borders of the enterocytes. Avidin biotin peroxidase, anti-CPE primary antibody, 400×. (d) Human colon treated with CPE in an Ussing chamber for 60 min. Avidin biotin peroxidase, normal rabbit serum (negative control), 400×. Bars, 40 μm (a and b) and 20 μm (c and d).

References

    1. Bartholomew, B. A., M. F. Stringer, G. N. Watson, and R. J. Gilbert. 1985. Development and application of an enzyme linked immunosorbent assay for Clostridium perfringens type A enterotoxin. J. Clin. Pathol. 38:222-228. - PMC - PubMed
    1. Birkhead, G., R. L. Vogt, E. M. Heun, J. T. Snyder, and B. A. McClane. 1988. Characterization of an outbreak of Clostridium perfringens food poisoning by quantitative fecal culture and fecal enterotoxin measurement. J. Clin. Microbiol. 26:471-474. - PMC - PubMed
    1. Bos, J., L. Smithee, B. A. McClane, R. F. Distefano, F. A. Uzal, G. Songer, S. Mallonee, and, J. M. Crutcher. 2005. Fatal necrotizing colitis following a foodborne outbreak of enterotoxigenic Clostridium perfringens type A infection. J. Clin. Infect. Dis. 40:e78-e83. - PubMed
    1. Chakrabarti, G., X. Zhou, and B. A. McClane. 2003. Death pathways activated in CaCo-2 cells by Clostridium perfringens enterotoxin. Infect. Immun. 71:4260-4270. - PMC - PubMed
    1. Dorr, R. A., A. Kierbel, J. Vera, and M. Parisi. 1997. A new data-acquisition system for the measurement of the net water flux across epithelia. Comput. Methods Programs Biomed. 53:9-14. - PubMed

Publication types